YU2397A - 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining - Google Patents

2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Info

Publication number
YU2397A
YU2397A YU2397A YU2397A YU2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A
Authority
YU
Yugoslavia
Prior art keywords
phenyl
aroylbenzothiophenes
medicaments
obtaining
hexamethyleneimino
Prior art date
Application number
YU2397A
Other languages
Serbo-Croatian (sh)
Serbian (sr)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Eli Lilly Company
Lilly Corporate Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly Company, Lilly Corporate Center filed Critical Eli Lilly Company
Publication of YU2397A publication Critical patent/YU2397A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

Opisana je upotreba jedinjenja formule I u kojoj su R1 i R3 nezavisno vodonik, -CH3, -C(=O)-(C1-C6 alkil), ili -C(O=)- Ar, gde je Ar opciono supstituisan fenil; R2 je izabran od grupe koja sadrži pirolidin, heksametilenimino i piperidino; ili farmaceutski prihvatljive soli i njihove rastvore; za dobijanje medikamenta upotrebljivog za inhibiciju kancera debelog creva.Described is the use of a compound of formula I wherein R 1 and R 3 are independently hydrogen, -CH 3, -C (= O) - (C 1 -C 6 alkyl), or -C (O =) - Ar, wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneimino and piperidino; or pharmaceutically acceptable salts and solutions thereof; to obtain a medicament useful for the inhibition of colon cancer.

YU2397A 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining YU2397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
YU2397A true YU2397A (en) 1999-11-22

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2397A YU2397A (en) 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Country Status (19)

Country Link
EP (1) EP0921799A4 (en)
JP (1) JP2000503994A (en)
KR (1) KR19990082054A (en)
CN (1) CN1209745A (en)
AR (1) AR010978A1 (en)
AU (1) AU707892B2 (en)
BR (1) BR9700778A (en)
CO (1) CO4761062A1 (en)
CZ (1) CZ235498A3 (en)
EA (1) EA001104B1 (en)
ID (1) ID15917A (en)
IL (1) IL125521A (en)
MX (1) MX9806036A (en)
NO (1) NO983451L (en)
NZ (1) NZ331105A (en)
PL (1) PL328147A1 (en)
TW (1) TW446560B (en)
WO (1) WO1997026877A1 (en)
YU (1) YU2397A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
IL111287A0 (en) * 1993-10-15 1994-12-29 Lilly Co Eli Methods for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
TW446560B (en) 2001-07-21
IL125521A (en) 2001-11-25
PL328147A1 (en) 1999-01-18
AR010978A1 (en) 2000-08-02
CN1209745A (en) 1999-03-03
NO983451D0 (en) 1998-07-27
AU707892B2 (en) 1999-07-22
BR9700778A (en) 1998-10-06
WO1997026877A1 (en) 1997-07-31
IL125521A0 (en) 1999-03-12
EP0921799A4 (en) 2002-03-13
JP2000503994A (en) 2000-04-04
EP0921799A1 (en) 1999-06-16
EA199800677A1 (en) 1999-02-25
ID15917A (en) 1997-08-21
EA001104B1 (en) 2000-10-30
KR19990082054A (en) 1999-11-15
NO983451L (en) 1998-07-27
CZ235498A3 (en) 1999-02-17
CO4761062A1 (en) 1999-04-27
NZ331105A (en) 2000-06-23
MX9806036A (en) 1998-11-29
AU2123997A (en) 1997-08-20

Similar Documents

Publication Publication Date Title
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
MY132251A (en) Methods of inhibiting cell-cell adhesion
ATE234094T1 (en) 2-PHENYL-3-AROYLBENZOTHIOPHENE FOR THE TREATMENT OF MENSTRUAL SYMPTOMS
MY132056A (en) Methods of inhibiting physiological conditions associated with an excess of neuropeptide y.
NO943878D0 (en) Inhibition of uterine fibrosis
MX9701329A (en) Methods of inhibiting viral replication.
ES2147399T3 (en) NEW DERIVATIVES OF 2,3,5-TRIMETIL-4-HIDROXIANILIDAS, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION.
MX9701325A (en) Methods of inhibiting ulcerative mucositis.
MX9701360A (en) Methods of inhibiting demyelinating and dysmyelinating diseases.
UA32427C2 (en) The use of benzothiophene or pharmaceutical acceptable salts or solvate thereof for inhibition of angiogenesis and/or angiogenic diseases
NO944930D0 (en) Inhibition of dysfunctional uterine bleeding
RS49965B (en) Substituted bisindolymaleimides for the inhibition of cell proliferation
NO943873D0 (en) Inhibition of cartilage degradation
FR2702477B1 (en) Benzoxazine derivatives, their preparation and their therapeutic application.
EA199800015A1 (en) METHOD OF INHIBITING MELANOMA
YU6996A (en) Benzothiophene application in preparation of medicine
TR199802456T2 (en) New pyrrole derivatives.
YU2397A (en) 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining
YU55495A (en) USE OF BENZOTHOPHENE TO OBTAIN MEDICINE
DK0904783T3 (en) Benzoe (b) thiophene derivatives for lowering platelet count
MX9702148A (en) Methods of inhibiting endometrial mitoses.
MX9701327A (en) Methods of inhibiting endometrial cancer.
RS50449B (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
DK0771201T3 (en) Use of 2-phenyl-3-aroylbenzothiophenes to prepare a drug for inhibiting primary endometrial hyperplasia
EA199800678A1 (en) METHOD OF INHIBITING MUSCULAR-APONURROTIC FIBROMATOSIS (DEMOID TUMORS)